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MTH1 hydrolyzes oxidized nucleotide triphosphates, thereby preventing them from being incorpo-
rated into DNA. We here present the structures of human MTH1 (1.9 Å) and its complex with the
product 8-oxo-dGMP (1.8 Å). Unexpectedly MTH1 binds the nucleotide in the anti conformation with
no direct interaction between the 8-oxo group and the protein. We suggest that the speciﬁcity
depends on the stabilization of an enol tautomer of the 8-oxo form of dGTP. The binding of the prod-
uct induces no major structural changes. The structures reveal the mode of nucleotide binding in
MTH1 and provide the structural basis for inhibitor design.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Oxygen radicals are produced as a byproduct of cellular metab-
olism. Reactive oxygen species (ROS) cause damage not only to the
DNA directly, but also to the free bases in the nucleotide pool,
resulting in for instance 8-oxo-dGTP, which can be misincorporat-
ed into DNA and if unrepaired can cause mutations in the second
round of replication by mispairing with thymine. The MutT Homo-
log 1 (MTH1) protein effectively degrades oxidized nucleotides, by
catalyzing for instance the hydrolysis of 8-oxo-dGTP to 8-oxo-
dGMP, and thereby preventing their incorporation into DNA. The
MTH1 protein belongs to the Nudix hydrolase superfamily, charac-
terized by a conserved 23-residue sequence segment (GX5EX7REU-
XEEXGU, U = I, L or V). A solution structure of MTH1 has previously
been reported [1]. MTH1 is present both in the nucleus and the
mitochondria where it also minimizes accumulation of 8-oxo-
guanine in DNA [2]. Indeed, MTH1/ knockout mice or cells siR-
NA depleted for MTH1 accumulate 8-oxo-G in their DNA and dis-
play a slight increase in mutation and cancer rates [3–5]. MTH1
also accepts other substrates such as 2-OH-dATP, 2-OH-rATP and
8-OH-dATP [6,7]. The production of the mono-phosphate, as op-chemical Societies. Published by E
.posed to the di-phosphate, is likely important to prevent regener-
ation of 8-oxo-dGTP by nucleotide di-phosphate kinase [8].
Effective supply of dGTP is essential for DNA replication. Hence,
it is of interest how MTH1 structurally recognize and distinguish
the 8-oxo-dGTP from dGTP. Here, we have resolved the crystal
structure of human MTH1 and report a distinct mechanism for rec-
ognition, different from that of the Escherichia coli MutT homolog.
2. Materials and methods
2.1. MTH1 expression, puriﬁcation and activity assay
cDNA encoding human MTH1 (NUDT1) and optimized for
expression in E. coli was purchased from Geneart AG. His tagged
MTH1 was expressed from pET-28a (Novagen) in E. coli BL-
21(DE3) (Stratagene). The bacteria were harvested, lysed using
BugBuster (Novagen) and His tagged MTH1 was afﬁnity puriﬁed
using HisTrap HP (Amersham Biosciences). The His tag was re-
moved by thrombin digestion (Novagen) and theMTH1 protein fur-
ther puriﬁed using anion exchange chromatography at pH 7.5 using
a MonoQ column (GE Healthcare). The identity and purity of the
protein was conﬁrmed using MALDI-TOF mass spectrometry. The
activity of MTH1 was monitored using 8-oxo-dGTP (TriLink Bio-
technologies) using the PPiLight™ Inorganic Pyrophosphate Assay
(Lonza Rockland Inc.). The enzyme activity was calculated usinglsevier B.V. All rights reserved.
Fig. 1. (A) Enzymatic activity of MTH1 with 8-oxo-dGTP. (B) Overall ribbon
representation of MTH1 in rainbow color representation, from the N-terminus
(blue) to the C-terminus (red). 8-oxo-dGMP is shown in stick representation.
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the data points to the Michaelis–Menten equation using non-linear
regression analysis utilizing the GraphPad Prism Software.
2.2. Crystallization
3 mM 8-oxo-dGTP, 6 mM MgCl2 and 2 mM TCEP was added to
MTH1 (16.9 mg/ml) in 20 mM Tris–HCl, pH 7.4, 0.15 M NaCl and
5% glycerol. A hanging drop experiment was set up, where 100 nl
protein solution was mixed with 100 nl well solution (26%
PEG6000, 0.1 M sodium acetate trihydrate, pH 4.0, 0.2 M Li2SO4).
The plate was stored at 20 C. A long, thin, rod-like crystal was
ﬂash frozen in liquid nitrogen without adding an additional cryo
protectant to the crystallization buffer. Apo MTH1 (8.5 mg/ml) in
buffer completed with 2 mM DTT replacing TCEP was crystallized
as the 8-oxo-dGMP complex above. Crystals appeared at the same
well solution conditions as above, the crystal was ﬂash frozen in li-
quid nitrogen after the addition of cryo solution (27% PEG6000,
160 mM Li2SO4, 80 mM sodium acetate trihydrate, pH 4.0,
160 mM NaCl and 15% glycerol).
2.3. Structure determination and model building
Molecular replacement was carried out using a dataset collected
at the Diamond synchrotron. The model was built and reﬁned in a
higher quality data set collected at 100 K at beamline BL14.1, BESSY.
Both datasetswere processed usingMOSFLMand SCALA in the CCP4
program suite [9]. Data collection and reﬁnement statistics are pre-
sented in Table 1. Balbes [10] and the template pdb ﬁle 3FK9 were
used formolecular replacement. ARP/wARP [11]was used for build-
ing the initial model, followed by iterative building cycles using
Coot [12] and Refmac5 [13], TLS was used. The coordinates and
structure factors for the structures presented in this paper were
deposited in the PDB under codes 3ZR1 (apo) and 3ZR0 (complex).
3. Results and discussion
3.1. Enzyme activity
The activity of the MTH1 protein was tested with 8-oxo-dGTP as
substrate. The catalytic parameters obtained were: KM 13.2 ±
2.5 lM, kcat 3.3 ± 0.3 s1, kcat/KM 0.25 ± 0.05 lM1 s1, Fig. 1A. The
determined KM value is in good agreement with previous studies
[7]. We determined the activity at 22 C and pH 7.5 which explains
the lower kcat/KM value obtained compared to the previously pub-
lished value of 0.81 lM1 s1 determined at 30 C and pH 8.0 [7].
The kinetic analysis shows that the protein preparation used for
crystallization experiments is highly active.Table 1
Data collection and reﬁnement statistics.
Apo 8-oxo-dGMP
Space group P212121 P212121
Cell parameters
a, b, c (Å) 59.5, 67.1, 80.1 59.5, 67.3, 80.0
Resolution (Å) 34–1.9 (2.0–1.9)a 34–1.8 (1.9–1.8)
Rmerge 0.10 (0.57) 0.081 (0.43)
hI/r(I)i 11.6 (3.3) 12.2 (3.3)
Completeness (%) 99.2 (97.8) 99.9 (100)
Redundancy 5.1 (5.0) 4.3 (4.3)
Wavelength (Å) 0.918 0.918
Rwork/Rfree (%) 19.3/24.5 19.9/24.6
R.M.S.D.
Bond lengths (Å) 0.022 0.024
Bond angles () 1.8 2.0
Ramachandran zone distribution (%) 93.8/6.2/0/0 93.4/6.6/0/0
a Values in parentheses are for highest-resolution shell.3.2. MTH1 structure and its product complex
The structure of MTH1 has the typical Nudix fold with an a/b/a
structure [14] arranged as a mixed b-sheet with one a-helix on
each side (Fig. 1B). The Nudix motif is located on helix one and con-
necting loops. The protein crystallized with two monomers in the
asymmetric unit. The A chains of the structures include residues
3–156. The B chains include residues 2–156, however residues
14–17 in the B chains were disordered and are not included in
the models. In the present crystal form, the B-chain appears less or-
dered with a slightly worse electron density. The structural
description is based on the better-deﬁned A-chains. The apo struc-
ture has an acetate molecule originating from the crystallization
buffer bound in the active site. During the preparation of this man-
uscript an apo structure of human MTH1 was deposited in the PDB
(3Q93). The structures are virtually identical; a detailed compari-
son is available as Supplementary information S1.
As expected, when the protein was co-crystallized with the sub-
strate 8-oxo-dGTP, the structure revealed that the reaction had ta-
ken place and the product (8-oxo-dGMP) complex structure was
obtained. The product base is bound in a pocket formed by the beta
sheet and helix two. The product complex shows that MTH1 binds
the nucleotide in the anti conformation and not in the syn confor-
mation as previously suggested based on nucleotide analog inter-
action studies [15]. The base in the MTH1 complex is thus
oriented in the opposite direction compared to the sugar
(Fig. 2A). This is in contrast to the MutT protein from E. coli that
binds 8-oxo-dGMP in the syn conformation [16] but similar to
Fig. 2. (A) A stereo representation of the binding of 8-oxo-dGMP to MTH1. Key hydrogen bonds in base recognition are displayed. 8-oxo-dGMP, residues coordinating 8-oxo-
dGMP and metal coordinating residues are shown in stick representation. Waters in the vicinity of the active site are displayed as red spheres. Hydrogen bond distances are
displayed. (B) Overlay of the MTH1 and E. coliMutT 8-oxo-dGMP complexes illustrating the large differences in deoxyribose and base orientations as well as the similarity in
the position of the a-phosphate. 8-oxo-dGMP is shown in stick representation with green carbons from the MutT complex and gray carbons from the MTH1 complex.
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(Fig. 2B). E. coliMutT has been intensively studied and is a founding
member of the Nudix family. MutT also catalyzes the hydrolysis of
8-oxo-dGTP, but has a low (21%) sequence identity to MTH1
[14,19].
3.3. Substrate hydrolysis
It has been shown that the b-phosphate of 8-oxo-dGTP is at-
tacked by water during hydrolysis. Oxygen originating from the
solvent water is introduced in the pyrophosphate product [1]. An
overlay with the E. coli MutT 8-oxo-dGMP complex reveals that
the position of the a-phosphate is almost identical between the
MTH1 and the MutT complex and the two proteins most likely uti-
lize a conserved site for substrate hydrolysis. Glu100, Glu56 and
Glu52 are positioned where they can coordinate a divalent cation
needed for activity (Fig. 2A). These residues are clustered close to
the position of the a-phosphate of 8-oxo-dGMP. The product com-
plex was crystallized in presence of Mg2+. Based on coordination
geometry, coordination distances and the electron density, magne-
sium does not appear to be bound to the protein complex. It is
however possible that the metal coordinates only to the substrate
triphosphate and dissociates upon product formation or binds to
the pyrophosphate product. A sequence alignment does not reveal
if Asp99 or Glu100 is important for metal coordination. Asp99
points away from the metal binding site and it has been shown
by mutagenesis that the Asp99Ala mutation retains a high activity
while the Glu100Ala mutant is inactive [1]. Glu100 is a metal-
coordinating residue located outside the Nudix motif. Lys23 coor-
dinate the a-phosphate of 8-oxo-dGMP.
3.4. Base recognition
The active site pocket of MTH1 is built up of residues Leu9,
Phe27, Phe72, Met81, Val83, Trp117, Trp123 and Phe139. The base
of dGMPmakes several hydrogen bonds in the recognition pocket ofMTH1. The hydrogen bonds to Asn33, Asp119 and Asp120 appear
most important and are discussed below.
The binding of the base is completely different when comparing
MTH1 and MutT (Fig. 2B) [16]. MTH1 binds 8-oxo-dGMP in the anti
conformation and MutT in the syn conformation, an approximately
180 difference of the torsion angle about the N-glycosidic bond.
The base–protein interactions are completely different and reveal
no structural conservation. This reveals that even though the pro-
teins share a conserved catalytic region, the nucleotide recognition
isnot conserved.Different evolutionary routeshavebeen taken, pos-
sibly to allow for the broader substrate speciﬁcity of MTH1. 8-oxo-
dGMPbinding induces a large loopmovement inMutT that is critical
for recognition [16]. 8-oxo-dGMP binding in MTH1, on the other
hand, induces no signiﬁcant structural changes and the active site
of MTH1 appears to be prearranged for substrate binding. The
R.M.S.D. between the apo and complex structure is merely 0.2 Å;
they are thus practically identical.
3.4.1. Trp117, pi stacking with the product base
Both Trp117 and Trp123 of MTH1 have been shown by trypto-
phanﬂuorescence tobe close to thenucleotidebinding site [20]. This
is conﬁrmedby the crystal structure that places these residueswith-
in approximately 3.5 Å of 8-oxo-dGMP. Trp117 pi-stacks with the
base of 8-oxo-dGMP and is essential in building up the substrate
binding pocket of MTH1. The Trp117Ala mutant does not hydrolyze
either 8-oxo-dGTP or 2-OH-dATP while the Trp117Tyr has activity
towards 2-OH-dATP [21]. The integrity of the two rings of the nucle-
otide base are important for binding, probably because of the ob-
served ring stacking [22].
3.4.2. Phe27
The product complex reveals that Phe27 directly interacts with
the product. The Phe27Ala mutation has been shown to reduce the
activity of MTH1 with 2-OH-dATP and 8-oxo-dGTP, the interaction
with the product explains the lower activity of the Phe27Ala muta-
tion [21].
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Asn33 has previously been shown by mutagenesis to be critical
for substrate binding and speciﬁcity [1]. The nitrogen of Asn33 is
hydrogen bonded to N3 of 8-oxo-dGMP, a good hydrogen bond
acceptor (2.8 Å) (Fig. 2A). The oxygenofAsn33accepts onehydrogen
bond from the 2-amino group (2.8 Å). Asn33 is critical to substrate
binding and is central for the interaction. Mutating Asn33 to Glu
abolishes the ability to hydrolyze 8-oxo-dGTP [1]. The Asn33Glu
mutation introduces a larger side chain and the 8-oxo-dGMP com-
plex shows that this would sterically block 8-oxo-dGTP binding.
The Asn33Ala mutation retains 14% activity with 8-oxo-dGTP [1].
3.4.4. Asp119, important for speciﬁcity
Asp119 forms one hydrogen bondwith the 6-oxo group (2.4 Å) of
the base. Its involvement in substrate binding is also observed in the
activities of theAsp119Ala andAsp119Asnproteinvariants. Themu-
tants retain approximately half activity towards 8-oxo-dGTP but
have almost no activity towards 2-OH-dATP [1,21]. This indicates
that the carboxyl group of Asp119 is crucial for the interaction with
2-OH-dATP. Asp119 makes a direct hydrogen bond with the 6-oxo
group in the 8-oxo-dGMP complex. The corresponding group in 2-
OH-dATP is an amino group. Likely, Asp119makes critical hydrogen
bonds to the 6-amino group and the N1 position of the enol form of
2-OH-dATP, explaining the deleterious effect of the Asp119 muta-
tions on the activity towards 2-OH-dATP.
3.4.5. Asp120, a key residue in binding
Asp119 of MTH1 has been addressed extensively in the litera-
ture while the following residue, Asp120, has attracted less inter-
est. The product complex of MTH1 reveals that Asp120 has a
fundamental role in the recognition of the base. The MTH1 struc-
ture suggests that this is the most important and central amino
acid in the recognition of the base. Asp120 is engaged in two
hydrogen bonds with the base, one with N1 (2.9 Å) and one with
the 2-amino group (2.8 Å) (Fig. 2A).
3.4.6. The 2-amino group of 8-oxo-dGTP
Both Asn33 and Asp120 make hydrogen bonds to the 2-amino
group of 8-oxo-dGMP, this position is central for the interaction.
This is in agreement with studies of MTH1 substrate recognition
using nucleotide analogs. Removing this group leads to a 10-fold
less efﬁcient degradation [15].
3.4.7. The 6-keto group of 8-oxo-dGTP
The 6-keto group of 8-oxo-dGTP is not critical for the interaction
with 8-oxo-dGTP. Its removal actually results in a substrate with
slightly higher afﬁnity for MTH1 [22]. Removal of the 6-keto group
and subsequent aromatization is accompanied by loss of the N1
hydrogen, making N1 a much better hydrogen bond acceptor. This
will make the hydrogen bond interaction between N1 and Asp120
more favorable, Asp120 donates a hydrogen bond to N1 and the
other oxygen of Asp120 accepts one hydrogen bond from the 2-ami-
no group of 8-oxo-dGTP. This is consistentwith the observation that
theenol formsof 2-OH-dATPanddisoITP areverygoodsubstrates for
MTH1 [22]. Thesenucleotides also lack ahydrogen in theN1position
and can therefore accept a hydrogen bond from Asp120.
3.5. Preference for deoxyribonucleotides
Interestingly, 8-oxo-dGTP is a considerably better substrate for
MTH1 than 8-oxo-GTP [6]. The oxygen of the carbonyl of Thr8
makes a hydrogen bond (2.7 Å) to the 3-hydroxyl-group of the 2-
deoxyribose sugar. There are no possibilities for favorable interac-
tions to the 2-hydroxyl-group of a ribose. The hydroxyl group
would, on the contrary, be directed into a hydrophobic pocket
composed of Leu9 and Val83, an unfavorable environment for this
group. We suggest that this could explain the lower activitytowards the ribonucleotide compared to the deoxyribonucleotide
[6]. This difference in activity is not observed in MutT that has sim-
ilar activity towards 8-OH-dGTP and 8-OH-GTP [23].
3.6. Recognition of the oxidized nucleotide
To our surprise, the structure of the 8-oxo-dGMP complex re-
vealed very few direct interactions between MTH1 and the 8-oxo
position of the oxidized base. The closest contacts between the 8-
oxo oxygen and MTH1 are to Met81 (3.3 Å) and Phe27 (3.5 Å).
The N7 hydrogen that accompanies the 8-oxo oxidation coordinates
onewatermolecule but is not in direct contact with the protein. The
N7 position is used by hOGG1 to discriminate between the oxidized
and the unoxidized forms of the nucleotide [18]. Comparison of the
apo structure and the product complex shows a slight movement of
the e-carbon of Met81 and insigniﬁcant change in the Phe27 posi-
tion. The contacts of the N7 hydrogen and the 8-oxo group appear
too weak to be responsible for the substrate speciﬁcity. The enzyme
needs to discriminate between the oxidized and the unoxidized
nucleotide. There is a 17-fold difference between the KM of dGTP
and 8-oxo-dGTP [6]. A 17-fold difference corresponds to an approx-
imate binding energy difference of 2.4 kcal/mol, roughly half the
energy of a hydrogen bond. This energy difference is in a range that
could be explained by preferred binding to the 6-enol-8-keto form
of 8-oxo-dGTP (Supplementary Fig. S2). A hydrogen bond donating
group, like an amino group or hydroxy (enol), in the 2 position ap-
pears to be very important for the overall afﬁnity [15]. A hydrogen
bond acceptor in the N1 position also appears important for binding
[15]. We speculate that the 1- and 6-position is critical for the spec-
iﬁcity and that the 6-enol-8-keto form of 8-oxo-dGTP is able to do-
nate and accept hydrogen bonds at these speciﬁc positions. The 8-
oxo group of 8-oxo-dGTP makes the 6-enol form a more prominent
and stable tautomer than for the un-oxidized nucleotide and sug-
gests that signiﬁcant levels of the 6-enol-8-keto form exists in solu-
tion [24]. The modiﬁcation also signiﬁcantly changes the
electrostatic potential of the base [25]. We thus hypothesize that
the basis for the difference in afﬁnity between oxidized and un-oxi-
dized nucleotide is that the 8-oxo modiﬁcation of the base inﬂu-
ences the keto-enol tautomerization and electrostatic properties
of the opposite side of the base, which makes several key interac-
tions with MTH1.
3.6.1. Hydrogen bonding to the 6-enol-8-keto form of 8-oxo-dGTP
The short hydrogen bond distance (2.4 Å) between Asp119 and
the OH group in position 6 of the 6-enol-8-keto form of 8-oxo-
dGTP (Fig. 2A) supports the presence of this tautomer. The strong
hydrogen bond implies an interaction between a negatively
charged (deprotonated) carboxylate and an OH group. The ob-
served hydrogen bonding pattern implicates that Asp120 is pro-
tonated, likely caused by effects of the local environment on its
pKa. Binding of the alternative, 6-keto-8-keto tautomer would re-
quire that at least Asp119 is protonated. Thus, in both cases at least
one of the carboxylate groups needs to be protonated.
3.7. Comparison of the NMR and crystal structures of MTH1
The R.M.S.D. between the NMR structure and the crystal struc-
ture of MTH1 is as high as 1.8 Å [1]. The core beta sheet has the
same structure but differences are present in several structural ele-
ments extending from the core sheet and surrounding the active
site (Fig. 3). There is a large difference in the position of Phe27
and its loop between the NMR and crystal structures, Phe27 inter-
acts with the product. Glu100 and neighboring residues also show
signiﬁcant differences between the crystal structures and the NMR
structure, Glu100 is a metal coordinating residue that is essential
for activity [1]. Two additional loops show signiﬁcant main chain
Fig. 3. An overlay of the C-alphas of the MTH1 complex crystal structure in blue
and the MTH1 NMR structure in red. Loops with signiﬁcant differences are
indicated. E100, F27 and 8-oxo-dGMP are shown in stick representation.
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of these differences may be explained by protein dynamics.
3.8. Possibilities for structure based drug design
It was recently demonstrated that MTH1 assists in eliminating
RAS-induced oxidative damage to prevent induction of senescence
[26]. Hence, any inhibitors of MTH1 may potentially increase the
amount of RAS-induced oxidative damage and thereby make can-
cer cells enter pre-mature senescence leading to reduced cancer
growth. This may be a very appealing strategy for treatment of can-
cer, also since the MTH1/ knockout mice show very mild symp-
toms and only have limited inductions of tumors with very late
onset. Thus, any MTH1 inhibitors are likely to have very few toxic
effects to normal cells. The MTH1 structure presented in this study
opens possibilities for structure based drug design for selectively
targeting MTH1.
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